Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Intra-Cellular Therapies Inc reports results for the quarter ended in March - Earnings Summary

* Intra-Cellular Therapies Inc  ITCI.OQ  reported a
quarterly
adjusted loss of 16 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -46 cents.  The mean expectation of
fourteen analysts for the quarter was for a loss of 32 cents per
share. Wall Street expected results to range from -47 cents
to -24 cents per share.
    * Revenue rose 52% to $144.87 million from a year ago;
analysts
expected $141.38 million. 
    * Intra-Cellular Therapies Inc's reported EPS for the
quarter was
a loss of 16 cents​.
    * The company reported a quarterly loss of $15.25 million.
    * Intra-Cellular Therapies Inc shares had risen by 2.6% this
quarter and lost 0.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Intra-Cellular
Therapies Inc is $91.00 
This summary was machine generated from LSEG data May 7 at 01:32
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.32          -0.16          Beat
 Dec. 31 2023      -0.44          -0.30          Beat
 Sep. 30 2023      -0.57          -0.25          Beat
 Jun. 30 2023      -0.59          -0.45          Beat

Recent news on Intra-Cellular Therapies

See all news